Literature DB >> 26348357

Immune Checkpoint Blockade in Cancer Therapy: The 2015 Lasker-DeBakey Clinical Medical Research Award.

James P Allison1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26348357     DOI： 10.1001/jama.2015.11929

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  34 in total

1.  Engineering of a novel subnanomolar affinity fibronectin III domain binder targeting human programmed death-ligand 1.

Authors:  Sindhuja Ramakrishnan; Arutselvan Natarajan; Carmel T Chan; Paramjyot Singh Panesar; Sanjiv S Gambhir
Journal:  Protein Eng Des Sel       Date:  2019-12-31       Impact factor: 1.650

2.  Targeted antibody and cytokine cancer immunotherapies through collagen affinity.

Authors:  Jun Ishihara; Ako Ishihara; Koichi Sasaki; Steve Seung-Young Lee; John-Michael Williford; Mariko Yasui; Hiroyuki Abe; Lambert Potin; Peyman Hosseinchi; Kazuto Fukunaga; Michal M Raczy; Laura T Gray; Aslan Mansurov; Kiyomitsu Katsumata; Masashi Fukayama; Stephen J Kron; Melody A Swartz; Jeffrey A Hubbell
Journal:  Sci Transl Med       Date:  2019-04-10       Impact factor: 17.956

3.  Where Is Health Care Headed?

Authors:  Jeffrey Bland
Journal:  Integr Med (Encinitas)       Date:  2016-06

Review 4.  The Next Generation of Immunotherapy for Cancer: Small Molecules Could Make Big Waves.

Authors:  William G Kerr; John D Chisholm
Journal:  J Immunol       Date:  2019-01-01       Impact factor: 5.422

5.  Non-Thermal Plasma-Induced Immunogenic Cell Death in Cancer: A Topical Review.

Authors:  Marian Khalili; Lynsey Daniels; Abraham Lin; Fred C Krebs; Adam E Snook; Sander Bekeschus; Wilbur B Bowne; Vandana Miller
Journal:  J Phys D Appl Phys       Date:  2019-08-06       Impact factor: 3.207

Review 6.  Induction of anti-cancer T cell immunity by in situ vaccination using systemically administered nanomedicines.

Authors:  Geoffrey M Lynn; Richard Laga; Christopher M Jewell
Journal:  Cancer Lett       Date:  2019-06-08       Impact factor: 8.679

7.  Biomimetic Glyconanoparticle Vaccine for Cancer Immunotherapy.

Authors:  Eliran Moshe Reuven; Shani Leviatan Ben-Arye; Hai Yu; Roberto Duchi; Andrea Perota; Sophie Conchon; Shirley Bachar Abramovitch; Jean-Paul Soulillou; Cesare Galli; Xi Chen; Vered Padler-Karavani
Journal:  ACS Nano       Date:  2019-03-11       Impact factor: 15.881

8.  Induction of antitumor immunity in mice by the combination of nanoparticle-based photothermolysis and anti-PD-1 checkpoint inhibition.

Authors:  Qizhen Cao; Wanqin Wang; Min Zhou; Qian Huang; Xiaoxia Wen; Jun Zhao; Sixiang Shi; Ku Geng; Fenge Li; Hiroto Hatakeyama; Chunyu Xu; David Piwnica-Worms; Weiyi Peng; Dapeng Zhou; Anil K Sood; Chun Li
Journal:  Nanomedicine       Date:  2020-02-12       Impact factor: 5.307

Review 9.  Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy.

Authors:  Jinfang Zhang; Fabin Dang; Junming Ren; Wenyi Wei
Journal:  Trends Biochem Sci       Date:  2018-10-01       Impact factor: 13.807

Review 10.  Chemical Tools To Monitor and Manipulate Adaptive Immune Responses.

Authors:  Todd M Doran; Mohosin Sarkar; Thomas Kodadek
Journal:  J Am Chem Soc       Date:  2016-05-03       Impact factor: 15.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.